AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2021
Aug 26, 2021
29755_dirs_2021-08-25_bf270605-3174-4128-b706-58158914d7d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-08-23
Reporting Person: Sorg Elaine K. (SVP, US Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-23 | Common Stock, $0.01 par value | S | 6000 | $120 | Disposed | 11595 | Direct |
| 2021-08-23 | Common Stock, $0.01 par value | M | 7080 | $114.36 | Acquired | 18675 | Direct |
| 2021-08-23 | Common Stock, $0.01 par value | S | 7080 | $120 | Disposed | 11595 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-23 | Option (Right to buy) | $114.36 | M | 7080 | Disposed | 2028-02-14 | Common Stock (7080) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Earnings Release
2026
Jul 6
Annual Report
2026
Jun 24
Call Transcript
2026
Jun 22
M&A Activity
2026
Jun 22
Call Transcript
2026
Jun 9
Regulatory Filings
2026
Jun 1
Call Transcript
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Call Transcript
2026
May 8